Marlborough biotech Sunovion Pharmaceuticals Inc. is preparing to market a new anti-seizure pill early next year following Food and Drug Administration approval of the medication.
Business - Boston.com, Boston Globe: Business
Mon, 11/11/2013 - 3:43pm
Marlborough biotech Sunovion Pharmaceuticals Inc. is preparing to market a new anti-seizure pill early next year following Food and Drug Administration approval of the medication.